These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33044635)

  • 1. [Infectious complications following prostate biopsy-Major changes 2020].
    Pilatz A; Bonkat G; Wagenlehner F
    Urologe A; 2020 Dec; 59(12):1486-1491. PubMed ID: 33044635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate biopsy 2021: current management].
    Wagenlehner F; Bonkat G; Pilatz A
    Aktuelle Urol; 2021 Aug; 52(4):356-359. PubMed ID: 33979884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostate biopsy-infection prophylaxis and patient preparation].
    Pilatz A; Alidjanov J; Bonkat G; Wagenlehner F
    Urologie; 2023 May; 62(5):459-463. PubMed ID: 36882551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
    Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
    Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Association of Urology Position Paper on the Prevention of Infectious Complications Following Prostate Biopsy.
    Pilatz A; Veeratterapillay R; Dimitropoulos K; Omar MI; Pradere B; Yuan Y; Cai T; Mezei T; Devlies W; Bruyère F; Bartoletti R; Köves B; Geerlings S; Schubert S; Grummet J; Mottet N; Wagenlehner F; Bonkat G
    Eur Urol; 2021 Jan; 79(1):11-15. PubMed ID: 33172721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group.
    Bjerklund Johansen TE; Kulchavenya E; Lentz GM; Livermore DM; Nickel JC; Zhanel G; Bonkat G
    Eur Urol Focus; 2022 Sep; 8(5):1483-1492. PubMed ID: 34920977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Strategies to Reduce Infectious Complications After Prostate Biopsy.
    Pilatz A; Veeratterapillay R; Köves B; Cai T; Bartoletti R; Wagenlehner F; Bruyère F; Geerlings S; Bonkat G; Pradere B
    Eur Urol Focus; 2019 Jan; 5(1):20-28. PubMed ID: 30503175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Pilatz A; Dimitropoulos K; Veeratterapillay R; Yuan Y; Omar MI; MacLennan S; Cai T; Bruyère F; Bartoletti R; Köves B; Wagenlehner F; Bonkat G; Pradere B
    J Urol; 2020 Aug; 204(2):224-230. PubMed ID: 32105195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
    Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
    World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Gu HM; Gu JS; Chung HS; Jung SI; Kwon D; Kim MH; Jung JH; Han MA; Kang SJ; Hwang EC; Dahm P
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241143
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
    Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
    Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
    Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
    World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.
    Jiang P; Liss MA; Szabo RJ
    J Urol; 2018 Aug; 200(2):361-368. PubMed ID: 29574110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy.
    Wenzel M; Welte MN; Theissen LH; Wittler C; Hoeh B; Humke C; Preisser F; Würnschimmel C; Tilki D; Graefen M; Roos FC; Becker A; Karakiewicz PI; Chun FKH; Kluth LA; Mandel P
    Eur Urol Focus; 2021 Sep; 7(5):980-986. PubMed ID: 33358884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis.
    Adibi M; Pearle MS; Lotan Y
    BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study.
    Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD
    Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.